High-performance frontal analysis (HPFA) was used for the protein binding study of catechin hydrate and genistein to human serum albumin (HSA). The experiment was performed on a Develosil 100Diol-5 column, and sodium phosphate buffer (pH 7.4 and ionic strength of 0.17) was used as the mobile phase. The mixtures of the drug-HSA solution were directly injected into the HPFA column, the HSA was eluted first and the unbound drugs were eluted out as a trapezoidal peak with a plateau region. The unbound drug concentration was determined from a plateau height of the plateau region and the experimental data were fitted by Scatchard equation. The binding constants (K) and binding affinities (nK) of the drug to HAS were K=1.32×10^(4) (L mol^(-1)), nK=0.47×10^(4) (L mol^(-1)) for catechin hydrate, and K=5.17×10^(4) (L mol^(-1)), nK=2.14×10^(4) (L mol^(-1)) for genistein.
El-Hady DA, Analytica Chimical Acta, 593, 178, 2007
Wu H, Chan W, Toxicology in Vitro, 21, 335, 2007
Chodon D, Ramamurty N, Sakthisekaran D, Toxicology in Vitro, 21, 887, 2007
Vergne S, Titier K, Bernard V, Asselineau J, Durand M, Lamothe V, Potier M, Perez P, Demotes-Mainard J, Chantre P, Moore N, Bennetau-Pelissero C, Sauvant P, Journal of Pharmaceutical and Biomedical Analysis, 43, 1488, 2007
Jin L, Choi D, Liu H, Row KH, Bulletin of Korean Chemical Society, 26, 136, 2005